Tomoe Akagami

Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non‐small cell lung cancer: Management of adverse events

Yu Miura, Atsuto Mouri, Kyoichi Kaira et al. · Thoracic Cancer · 2020 · 55 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Pre‐existing interstitial lung disease does not affect prognosis in non‐small cell lung cancer patients with <scp>PD‐L1</scp> expression ≥50% on first‐line pembrolizumab

Ou Yamaguchi, Kyoichi Kaira, Shun Shinomiya et al. · Thoracic Cancer · 2020 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The product of trunk muscle area and density on the CT image is a good indicator of energy expenditure in patients with or at risk for COPD

Toru Shirahata, Hideaki Sato, Sanehiro Yogi et al. · Respiratory Research · 2021 · 17 citations · Full text

Medicine, Physiology, Radiology +15

Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers

Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi et al. · Frontiers in Oncology · 2021 · 13 citations · Full text

Life Sciences, Immunology, Oncology +17

Energy expenditure and physical activity in COPD by doubly labelled water method and an accelerometer

Hideaki Sato, Hidetoshi Nakamura, Yuki Nishida et al. · ERJ Open Research · 2021 · 10 citations · Full text

Education, Physical Medicine, Physical Activity +15